US 11992531
C3-carbon linked glutarimide degronimers for target protein degradation
granted A61KA61K31/45A61K31/451
Quick answer
US patent 11992531 (C3-carbon linked glutarimide degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/45, A61K31/451, A61K31/454, A61K31/4545